Skadden, Arps, Slate, Meagher & Flom, which has been enjoying an impressive streak of transactions to start 2017, is one of three Am Law 100 firms advising on a proposed $24 billion cash-and-stock deal that will see Becton, Dickinson & Co. acquire medical device manufacturing rival C.R. Bard Inc.
The mega-merger, announced Sunday, will create a powerhouse in the medical supply and technology sector if it closes as expected by the fall of this year. Skadden M&A partners C. Michael Chitwood, Paul Schnell and Thomas Greenberg are leading a team from the firm advising Franklin Lakes, New Jersey-based BD. All three Skadden partners counseled BD in 2014 on its $12.2 billion buy of medical technology company CareFusion Corp.
